Friday, Becton, Dickinson And Company (BDX) announced the completion of its acquisition of HandyLab, Inc., an Ann Arbor, Michigan-based company that develops and manufactures molecular diagnostic assays and automation platforms.
In May 2009, BD and HandyLab announced an exclusive agreement for BD to develop and commercialize molecular assays on the HandyLab Jaguar platform, incorporating clinical sample preparation, nucleic acid extraction, and microfluidic real-time polymerase chain reaction or PCR amplification and detection in a simple bench-top system. The self-contained workstation is designed to accommodate both batch workflows and on-demand testing for maximum lab efficiency and flexibility.
For comments and feedback: editorial@rttnews.com